Patent Application
20190030355
The present invention is in the field of methods of increasing and sustaining free radical levels in a targeted tissue of interest. More specifically, the field of the invention is in the field of methods utilizing metal loaded nanoparticles and a free radical-producing stimulus.
A magnetic field of appropriate field strength affects the reaction dynamics of free radicals by quantum mechanisms which alter the spin dynamics of the free radicals. The radicals precess by a mechanism comparable to Larmor Precession. Free radicals are produced when tissues are irradiated by external photon, electron or particle beams or by exposure to a drug or therapeutic agent. Some chemotherapeutic agents employed in tumor treatment also produce their effect largely on the basis of free radical mechanisms. A magnetic field alters the reaction dynamics and results in increased cell injury when tissues and specifically tumor tissues are exposed to a structured magnetic field designed to treat the tissue exposed to an induced free radical concentration.
The following embodiments and aspects thereof are described and illustrated in conjunction with systems, tools and methods which are meant to be exemplary and illustrative, not limiting in scope. In various embodiments, one or more of the above-described problems have been reduced or eliminated, while other embodiments are directed to other improvements.
In a first separate aspect, the present invention may take the form of a method of creating and sustaining an elevated level of free radicals in a volume of targeted tissue that utilizes targeted nanostructures that include a metallic component that acts to amplify the effects of a free radical-producing stimulus; a magnetic component; and a binding component that acts to bind to cellular components present in the targeted tissue. To practice the method, the targeted nanostructures are introduced into the targeted tissue and a free radical-producing stimulus is provided at the targeted tissue volume.
In a second separate aspect, the present invention may take the form of a nanostructure adapted to facilitate treatment of targeted tissue, comprising a metallic component that acts to amplify the effects of free radical-producing stimulus; a magnetic component; and a binding component that binds to cellular features present in the targeted tissue.
In a third separate aspect, the present invention may take the form of a method of creating and sustaining an elevated level of free radicals in a volume of targeted tissue that uses targeted nanostructures that include a metallic component that acts to amplify the effects of a free radical-producing stimulus, and a binding component that acts to bind to cellular components present in the targeted tissue. To practice the method, the targeted nanostructures are introduced into the targeted tissue and a free radical-producing stimulus is performed at the targeted tissue. Further, a magnetic field is created and shaped to cover the targeted tissue and has a field strength of between 1 and 300 gauss at the targeted tissue, thereby extending lifetimes of free radicals in the targeted tissue.
In addition to the exemplary aspects and embodiments described above, further aspects and embodiments will become apparent by reference to the drawings and by study of the following detailed descriptions.
Exemplary embodiments are illustrated in referenced drawings. It is intended that the embodiments and figures disclosed herein are to be considered illustrative rather than restrictive.
In the context of this application, a “particle beam” is any beam of particles, including electrons or photons, in addition to charged particles.
In one preferred embodiment, a combination of irradiation and a low intensity magnetic field exposure produces enhances cell death through the use of metallic nanostructures. This term encompasses quantum wells, nanotubes and nanowires, and quantum dots, which can be formulated to incorporate metals, including gold, copper, silver, titanium, zinc or cadmium or technetium. In one preferred embodiment tissue is treated with zinc loaded, tissue targeted nanostructures that enhance free radical dynamics in irradiated tissue. In an additional preferred embodiment, chemotherapeutic agents, including but not limited to bleomycin, adriamycin and platinum compounds which act through free radical mechanisms induce an enhanced cell death and apoptosis when the tumor is treated with localized metallic nanomaterials which increase the effective cellular free radical concentration. Nanomaterials and specifically those incorporating metallic nanostructures enhance the free radical effect by increasing the effective concentration of free radicals in the tumor. The nanomaterials can be localized to the tumor by methods that include antibody tumor cell specific binding. The result is increased cell death in tissues jointly treated with the magnetic field, induced free radicals and tumor localized and concentrated nanometallic materials.
When nanoparticles are used, in preferred embodiments they include antibodies or aptamers that selectively attach to specific cell components, such as the cell wall, nucleoplasm, mitochondria, or ribosomes, or some combination of cell components. In a preferred method, a liquid suspension of nanoparticles is injected at a venous site, or alternatively, directly into the target tissue. Selective attachment can be accomplished by attaching a metallic portion of the nanoparticles to a tumor specific antibody or aptamer e.g. carcinoembryonic antigen (CEA), prostate-specific antigen (PSA) or synthetic antibody-like congeners. In a preferred embodiment, selective concentration of the nanoparticles is effected by injection, painting, or by using localized magnetic fields to concentrate magnetic particles. In an additional preferred embodiment, an endoscopic method or a trans vascular method is used to introduce nanomaterials at a specific anatomic site, which may be a tumor site.
In some preferred embodiments, anatomic localization of the nanomaterials is confirmed by imaging, for example: ultrasound imaging, computerized axial tomography, magnetic resonance imaging or specifically designed nuclear medicine imaging employing labelled nanomaterials. In one preferred method nanomaterials are concentrated at an anatomic location, which is then imaged. The resultant image information is then used to conform a magnetic field of selective strength to that anatomic location. Contemporaneously, the anatomic location is treated with external beam or by implanting a radiation source for therapeutic purposes in or near the anatomic site of the tumor or by targeting an anatomic site of interest with a radioisotope loaded nanostructure that induces free radicals. In a preferred embodiment, the radioisotope is iodine-131.
Metals that may be used in the nanostructures include high Z metals, such as copper, gold and zinc or transition metals from groups 3 through 12 of the periodic table of elements.
The advantages of the methods described above include enhanced free radical reactivity in tissue treated with a magnetic field conformed to the irradiated area at a selective magnetic field strength. Additional benefit is derived from nanomaterials that localize and increase free radical activity in treated tissue e.g. a treated tumor. The use of imaging to define the anatomic location, to confirm the localization of the employed nanomaterials, to design and confirm the magnetic field and define and confirm a selective magnetic field strength and guide the irradiation of the anatomic site provides further benefit.
Referring to
The magnetic field 22 conforms to the tumor anatomy to be irradiated and is monitored to establish the field strength and anatomic conformity. The patient then undergoes planned irradiation. The presence of the magnetic field 22 coupled with the metallic platinum nanostructures 16 results in enhanced tumor cell death in the irradiated tumor. The localization of the platinum nanostructures 16 to tumor cells and the anatomic conformity of the magnetic field concentrate the free radical damage to the tumor and mitigates injury to normal adjacent tissue.
Referring to
The present invention finds industrial applicability in the design and production of nanostructures.
The present invention may include the following forms:
A method of creating and sustaining an elevated level of free radicals in a volume of targeted tissue that utilizes targeted nanostructures that include a metallic component that acts to amplify the effects of a free radical-producing stimulus; a magnetic component; and a binding component that acts to bind to cellular components present in the targeted tissue. To practice the method, the targeted nanostructures are introduced into the targeted tissue and a free radical-producing stimulus is provided at the targeted tissue volume.
Preferred methods may include the following features, either singly or in combination: The metal portion includes zinc. The free radical-producing stimulus is an externally-created particle beam directed at said targeted tissue; The particle beam is comprised of electrons; The particle beam is comprised of photons; The particle beam is comprised of charged particles; The magnetic components of the nanostructures collectively produce a magnetic field that has a strength of between 1 and 300 Gauss; The binding portion is an antibody; The binding portion is an aptamer; The target tissue is cancerous; The metal portion includes a metal selected from a group consisting essentially of zinc, cadmium and technetium; The metal portion includes a metal selected from a group consisting essentially of copper, silver and gold; The cellular features are on the nuclear membranes of cells of said target tissue; The cellular features are on the cell membranes of cells of said target tissues; The nanostructures further include a radioisotope that serves as the free radical-producing stimulus; The radioisotope is iodine-131; The magnetic component comprises ferromagnetic material; Introducing the nanoparticles into the targeted tissue, includes providing a liquid suspension of said nanoparticles and injecting said nanoparticles into a venous site; and/or Introducing said nanoparticles into said targeted tissue, includes providing a liquid suspension of said nanoparticles and injecting said liquid suspension on nanoparticles directly into said targeted tissue.
A nanostructure adapted to facilitate treatment of targeted tissue, comprising a metallic component that acts to amplify the effects of free radical-producing stimulus; a magnetic component; and a binding component that binds to cellular features present in the targeted tissue.
Preferred nanostructures may include the following features, either singly or in combination: The metal portion includes zinc. The magnetic components of the nanostructures collectively produce a magnetic field that has a strength of between 1 and 300 Gauss; The binding portion is an antibody; The binding portion is an aptamer; The target tissue is cancerous; The metal portion includes a metal selected from a group consisting essentially of zinc, cadmium and technetium; The metal portion includes a metal selected from a group consisting essentially of copper, silver and gold; The cellular features are on the nuclear membranes of cells of said target tissue; The cellular features are on the cell membranes of cells of said target tissues; The nanostructures further include a radioisotope that serves as the free radical-producing stimulus; and/or The radioisotope is iodine-131; The magnetic component comprises ferromagnetic material.
A method of creating and sustaining an elevated level of free radicals in a volume of targeted tissue that uses targeted nanostructures that include a metallic component that acts to amplify the effects of a free radical-producing stimulus, and a binding component that acts to bind to cellular components present in the targeted tissue. To practice the method, the targeted nanostructures are introduced into the targeted tissue and a free radical-producing stimulus is performed at the targeted tissue. Further, a magnetic field is created and shaped to cover the targeted tissue and has a field strength of between 1 and 300 gauss at the targeted tissue, thereby extending lifetimes of free radicals in the targeted tissue.
While a number of exemplary aspects and embodiments have been discussed above, those possessed of skill in the art will recognize certain modifications, permutations, additions and sub-combinations thereof. It is therefore intended that the following appended claims and claims hereafter introduced are interpreted to include all such modifications, permutations, additions and sub-combinations as are within their true spirit and scope.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US17/14923 | 1/25/2017 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 62286474 | Jan 2016 | US |
